BEAHTORLI
Dead / Abandoned — Abandoned — failure to respond (as of 28 Aug 2023)
What this means for you
This application is over — abandoned 14 Aug 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97623315
- Mark type
- Stylized text
- Filed
- 07 Oct 2022
- Abandoned
- 14 Aug 2023
- Attorney of record
- Janet P. Peyton
Goods and services
- Class 005 — Pharmaceuticals: (Based on Intent to Use) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat; Pharmaceutical preparations for containing feniralstat(Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of angioedema; Pharmaceutical preparations for the treatment of hereditary angioedema; Pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; Pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; Pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; Pharmaceutical preparations for containing sebetralstat; Pharmaceutical preparations for containing feniralstat
Owner
- Kalvista Pharmaceuticals Limited, Wiltshire, GB
Prosecution history
- 29 Aug 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 28 Aug 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 28 Aug 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 12 May 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 May 2023 — NON-FINAL ACTION E-MAILED
- 12 May 2023 — NON-FINAL ACTION WRITTEN
- 05 May 2023 — ASSIGNED TO EXAMINER
- 24 Oct 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Oct 2022 — NEW APPLICATION ENTERED